TMFC is described as outperforming IVV historically and showing strength on some factor measures, including growth, but its appeal weakens versus the Invesco NASDAQ 100 ETF. The article characterizes TMFC's factor profile as softer and its returns as notably weaker in that comparison. Overall, the piece is a relative underperformance assessment rather than a company-specific catalyst.
TMFC’s problem is not that it is a bad factor fund; it is that the market has already paid for the same factor cocktail in a more liquid, better understood wrapper. Once you benchmark it against QQQ/QQQM, the marginal alpha case weakens because the portfolio is effectively competing against a more efficient expression of the same growth tilt, while still carrying enough idiosyncratic stock-selection risk to underwrite tracking error. That usually leads to a gradual asset-allocation bleed, not a dramatic price collapse: the risk is multiple compression from persistent underperformance versus the de facto benchmark, not an immediate fundamental break.
The second-order effect is flow-driven. If advisors and retail investors perceive TMFC as an “active-like beta” sleeve that cannot consistently beat the NASDAQ 100 over a full cycle, assets can migrate toward lower-fee, higher-liquidity substitutes. That would pressure TMFC’s trading volume and widen the performance feedback loop, since thinner vehicles are more vulnerable to redemptions during drawdowns. In contrast, QQQ benefits from being the default growth allocation, and even IVV can pick up capital from investors who decide the growth premium is no longer worth paying for.
The contrarian angle is that TMFC may still outperform in a broader dispersion regime if the market leadership narrows beyond mega-cap tech and into higher-beta growth names. If rates fall or breadth improves, a rules-based growth basket with less concentration than QQQ can look better on a forward basis than it does on a trailing one. The key catalyst window is 3-12 months: if the next leg of the market is led by unprofitable growth or mid-cap tech, TMFC’s factor mix could re-rate quickly; if not, relative underperformance likely persists.
Net: this is a relative-value story, not an absolute one. The setup favors either using TMFC only as a tactical satellite allocation during risk-on breadth expansions, or fading it versus the more liquid NASDAQ exposure until performance leadership broadens meaningfully.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
mildly negative
Sentiment Score
-0.25